Amira Pharmaceuticals Announces Appointment of First Chief Executive Officer
Amira Pharmaceuticals announced that the company has appointed Robert F. Baltera, Jr., as the company's first chief executive officer, effective immediately.
Before becoming Amira's CEO, Baltera held a number of senior management positions at Amgen, most recently as vice president of corporate and contract manufacturing. A scientist by training, Baltera joined Amgen at the beginning of his career as a research associate but quickly moved to the operations side of the business, working in finance, product development and commercial operations. He successfully used that collective experience to serve as team leader responsible for the approval of Kineret(TM) in rheumatoid arthritis, a highlight of his many accomplishments while at Amgen.
Baltera has a master's of business administration from the Anderson School at UCLA. He earned his bachelor's degree in microbiology and a master's degree in genetics from The Pennsylvania State University.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
